These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4). Jain M; Bakutis E; Gayle T; Lansky P Neurobiology; 1974; 4(3):180-90. PubMed ID: 4367441 [No Abstract] [Full Text] [Related]
23. [Recent data on monoamines of the brain]. Vîlciu S; Manolescu J Neurol Psihiatr Neurochir; 1974; 19(1):1-10. PubMed ID: 4596187 [No Abstract] [Full Text] [Related]
24. [The role of serotonin in affective disorders (author's transl)]. Lingjaerde O Encephale; 1979; 5(5 Suppl):499-506. PubMed ID: 95007 [No Abstract] [Full Text] [Related]
25. A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances. Rosengarten H; Friedhoff AJ Schizophr Bull; 1976; 2(1):90-105. PubMed ID: 779022 [No Abstract] [Full Text] [Related]
26. Biogenic amines and their impact in psychiatry. Axelrod J Semin Psychiatry; 1972 Aug; 4(3):199-210. PubMed ID: 4680221 [No Abstract] [Full Text] [Related]
27. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209 [No Abstract] [Full Text] [Related]
28. Pharmacologic studies on the structure-activity relationship of hydroxyindole alkylamines. Cerletti A; Taeschler M; Weidmann H Adv Pharmacol (1962); 1968; 6(Pt B):233-46. PubMed ID: 5658327 [No Abstract] [Full Text] [Related]
29. [Histochemistry of monoamine metabolism]. Shimizu N Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):851-8. PubMed ID: 4898005 [No Abstract] [Full Text] [Related]
31. Uptake, storage, and distribution of amines in bovine adrenal medullary vesicles. Slotkin TA; Kirshner N Mol Pharmacol; 1971 Nov; 7(6):581-92. PubMed ID: 4948239 [No Abstract] [Full Text] [Related]
32. [The drug experience as a biological problem]. Stille G Schweiz Med Wochenschr; 1971 Sep; 101(35):1257-69. PubMed ID: 4947024 [No Abstract] [Full Text] [Related]
33. Some aspects of the mechanism of action of various stimulant amphetamine analogues. Scheel-Krüger J Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652 [No Abstract] [Full Text] [Related]
34. Biochemical aspects of depression. Coppen AJ Int Psychiatry Clin; 1969; 6(2):53-81. PubMed ID: 5817856 [No Abstract] [Full Text] [Related]
35. Indoleamines and the central nervous system; a sounding of their clinical significance. van Praag HM Psychiatr Neurol Neurochir; 1970; 73(1):9-36. PubMed ID: 4313906 [No Abstract] [Full Text] [Related]
36. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice. Saavedra JM; Fischer E Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068 [No Abstract] [Full Text] [Related]
37. Blood platelets as a model for monoamine-containing neurones. Sneddon JM Prog Neurobiol; 1973; 1(2):151-98. PubMed ID: 4273118 [No Abstract] [Full Text] [Related]
38. Pharmacology of the central nervous system. Shellenberger MK; Walaszek EJ Prog Neurol Psychiatry; 1972; 27():67-86. PubMed ID: 4145416 [No Abstract] [Full Text] [Related]
39. Effect upon the analgesic action of reserpine of central nervous system stimulants and drugs affecting the metabolism of catechol- and indole-amines. LEME JG; ROCHA E SILVA M J Pharm Pharmacol; 1963 Jul; 15():454-60. PubMed ID: 13929554 [No Abstract] [Full Text] [Related]
40. Methylation & schizophrenia. Beaton JM Ala J Med Sci; 1975 Apr; 12(2):193-202. PubMed ID: 1096652 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]